Female Low Sex Drive Treatment: Causes, Options, and When to Get Care

Female low sex drive can come from stress, relationship strain, depression, medications, pain with sex, menopause, hormone changes, or hypoactive sexual desire disorder. Treatment depends on the cause and may include counseling, medication changes, treating pain or mood symptoms, hormone care, or prescription options such as bremelanotide for eligible premenopausal women.

What does low sex drive in women mean?

Female low sexual desire means less interest in sex, fewer sexual thoughts, or less openness to sexual activity than feels normal for you. It becomes a health concern when it causes personal distress, relationship strain, or a major change from your usual pattern; clinical trial standards for female sexual dysfunction also stress distress, context, reproductive status, and patient-reported outcomes over desire alone 1.

Low desire versus low arousal, pain, or orgasm concerns

Desire is the “wanting” part of sex. Arousal is the body’s response, such as lubrication and genital blood flow. Orgasm concerns and pain with sex, also called dyspareunia, are different problems, though they can overlap with low libido; female sexual dysfunction research separates these concerns because each may need a different care path 1.

When low desire becomes a health concern: distress, duration, and context

A lower sex drive is not automatically a disorder. Clinicians look at whether the change is persistent, causes distress, is not better explained by pain, relationship safety, severe stress, or another condition, and whether it is acquired rather than lifelong in some diagnoses 2.

Why libido naturally changes across life stages

Libido can shift during postpartum recovery, breastfeeding, perimenopause, menopause, illness, grief, sleep loss, and high-stress seasons. Menopause can also bring vaginal dryness, hot flashes, sleep changes, and mood symptoms, which may lower interest in sex even when desire was strong before; our guide to side effects of menopause explains these changes in more detail.

Why don’t I want to have sex anymore?

Low libido in women usually has more than one driver. The most useful question is not “Which pill raises libido?” but “What changed in my body, mind, relationship, medications, or life?”

Stress, fatigue, sleep problems, and mental health

Stress and poor sleep can lower desire by keeping the nervous system in a threat mode rather than a connection mode. Depression and anxiety can also reduce desire, arousal, energy, and pleasure; clinical evaluation of female sexual dysfunction is expected to account for comorbid conditions and psychological context 1.

Relationship conflict, safety, communication, and mismatched desire

Desire is affected by emotional safety, resentment, pressure, conflict, and mismatched expectations. Expert standards for female sexual dysfunction trials note that partner factors and interpersonal context matter when judging symptoms and treatment response 1.

Medication effects, including antidepressants

Selective serotonin reuptake inhibitors, or SSRIs, can lower desire, delay orgasm, or make arousal harder for some women. In one randomized trial, sildenafil improved sexual function in women with SSRI-associated sexual dysfunction, while a larger trial in HSDD not related to SSRIs did not show the same benefit, which is why the cause matters 3.

Hormone changes during postpartum, breastfeeding, perimenopause, and menopause

Lower estrogen can contribute to vaginal dryness, pain with sex, and urinary or vaginal symptoms, especially after menopause. Treating these symptoms can make sex more comfortable, but hormone therapy is not a universal low-libido treatment; the North American Menopause Society notes that hormone therapy decisions should be individualized based on symptoms, risks, and goals 4.

Pain with sex, vaginal dryness, and pelvic health conditions

Pain often turns desire down because the brain learns that sex may hurt. Vaginal dryness, pelvic floor tension, endometriosis, vulvar pain, infections, and bladder symptoms can all affect desire and should be evaluated before a libido medication is chosen.

Medical conditions that can affect desire

Diabetes, thyroid disease, chronic pain, inflammatory disease, fatigue syndromes, and some neurologic conditions can affect desire through hormones, circulation, pain, mood, or energy. A clinician may check targeted labs when symptoms point that way, but labs alone often do not explain desire.

What should be checked before choosing a treatment?

Before choosing a female low sex drive treatment, the first step is a careful history. A good evaluation looks at symptoms, timing, distress, medications, pain, mental health, relationship safety, reproductive stage, and medical conditions; trial standards also emphasize symptom duration, severity, and comorbid sexual concerns 1.

• A medical review: pregnancy or postpartum status, breastfeeding, menopause symptoms, thyroid symptoms, diabetes risk, chronic pain, fatigue, and recent illness.
• A medication review: SSRIs, SNRIs, hormonal contraception, blood pressure drugs, opioids, sedatives, and other medicines can affect libido.
• Mood and safety screening: depression, anxiety, trauma, coercion, pressure, and relationship safety change the care plan.
• Pelvic symptoms: dryness, burning, tearing pain, deep pelvic pain, bleeding, discharge, bladder pain, or recurrent infections need specific evaluation.
• Labs when useful: thyroid tests, diabetes screening, pregnancy testing, iron or vitamin testing, or hormone labs may help in selected cases, but no single “libido lab” diagnoses most low desire.

What non-prescription steps can help low libido?

Non-prescription care is often the strongest starting point because many causes are not solved by a libido drug. In female sexual dysfunction research, meaningful improvement must be judged against context, distress, and patient-reported outcomes, not just a number on a scale 1.

• Improve sleep and recovery. Desire often falls when the body is exhausted or under constant stress.
• Reduce alcohol if it is affecting arousal, mood, sleep, or relationship conflict.
• Use couples communication or sex therapy when pressure, resentment, avoidance, or mismatched desire is part of the pattern.
• Consider pelvic floor physical therapy when sex is painful, tense, or associated with pelvic symptoms.
• Use lubricants during sex and vaginal moisturizers between sexual activity when dryness is present.
• Move your body in ways that feel sustainable. Exercise may support mood, energy, body image, and cardiometabolic health.

What prescription treatments are used for low sex drive in women?

Prescription treatment depends on the cause and the person’s reproductive stage. Benefits must be weighed with side effects, contraindications, pregnancy status, medication interactions, and whether the treatment was studied in a similar group.

Bremelanotide, also called PT-141, for certain premenopausal women with acquired generalized HSDD

Bremelanotide, also called PT-141, is a melanocortin receptor agonist. The FDA-approved product label is for an injection used as needed before anticipated sexual activity in premenopausal women with acquired, generalized hypoactive sexual desire disorder, or HSDD, and it is not indicated for HSDD due to relationship problems, medical or psychiatric conditions, or medication effects 2.

In the FDA label, common adverse reactions included nausea, flushing, injection-site reactions, and headache, and the label warns against use in people with uncontrolled hypertension or known cardiovascular disease because it can raise blood pressure and lower heart rate after dosing 2. Individual results vary.

Flibanserin for certain premenopausal women with acquired generalized HSDD

Flibanserin is a serotonin 1A receptor agonist and serotonin 2A receptor antagonist. The FDA label is for acquired, generalized HSDD in premenopausal women, but it carries important warnings about severe low blood pressure and fainting with alcohol, certain liver issues, and interacting medicines 5.

Hormone therapy when menopause symptoms or vaginal symptoms are part of the picture

Estradiol, an estrogen therapy, may help menopause-related vaginal dryness, painful sex, hot flashes, and sleep disruption when those symptoms are part of low desire. Progesterone may be used with systemic estrogen for people with a uterus to reduce endometrial risk, but hormone therapy choices depend on medical history and risk factors 4.

Testosterone: evidence, off-label use, and safety limits

Testosterone, or androgen therapy, has evidence for postmenopausal women with HSDD, but use for female sexual dysfunction may be off-label in the US. In randomized trials summarized in The Journal of Family Practice, a 300-mcg transdermal testosterone patch improved satisfying sexual episodes and desire scores in postmenopausal women, but unwanted hair growth was more common and trials were not long enough to fully assess cardiovascular risk 3.

Bupropion or antidepressant changes when medication side effects are suspected

Bupropion has been studied in randomized trials for premenopausal women with HSDD and may help some people, but it is not licensed specifically for this use and may not be right for people with seizure risk or certain eating disorders 3. If an antidepressant seems linked to low desire, changes should be clinician-guided rather than abrupt.

Sildenafil: where evidence is limited and when it may apply

Sildenafil is a phosphodiesterase type 5 inhibitor. Evidence is mixed: it improved sexual function in one randomized trial of women with SSRI-associated sexual dysfunction, but it did not beat placebo in a larger trial of HSDD unrelated to SSRIs 3. Side effects can include headache, flushing, nasal congestion, and blood pressure interactions.

PT-141 at Chia: nasal spray access through clinician-reviewed telehealth

At Chia, PT-141 nasal spray is available through clinician-reviewed telehealth for patients whose history suggests it may be appropriate. Plans currently start at $159/mo, and the product page has current details: PT-141 nasal spray.

Here is how care works: you complete a short online health questionnaire, a licensed US provider reviews your information, and medication is prescribed only when clinically appropriate. If prescribed, treatment is compounded in the US by a state-licensed 503A pharmacy and shipped to your door.

Dosing must be provider-guided and individualized. This is especially important with PT-141 because the FDA-approved bremelanotide injection label includes blood pressure warnings and contraindications for uncontrolled hypertension or known cardiovascular disease 2. For more education, read our guides to the PT-141 dosage chart and why buying PT-141 on Amazon is not the same as getting clinician-reviewed care.

How do treatments compare for different causes of low desire?

Low desire treatment works best when the care path matches the cause. A medication that helps one group may not help another, which is why female sexual dysfunction studies separate reproductive status, distress, comorbidities, and clinically meaningful change 1.

What popular libido fixes do not have strong evidence?

Supplements and “libido boosters” are often marketed with stronger claims than the evidence supports. Many have not been tested in high-quality female sexual dysfunction trials that measure distress, satisfying sexual events, safety, and patient-reported outcomes over enough time 1.

• Be cautious with over-the-counter hormone products, especially if they claim to balance estrogen, progesterone, or testosterone without testing or medical review.
• Be cautious with “research chemical” peptide vendors. A licensed-provider path and state-licensed pharmacy are different from no-prescription products sold online.
• Do not assume low libido is always low testosterone. Testosterone can help selected postmenopausal women with HSDD in studies, but safety limits and off-label status matter 3.

When should someone get medical help quickly?

Get medical help now if low desire comes with symptoms that could signal infection, bleeding, severe pain, or a safety crisis. Libido can wait; pelvic emergencies and personal safety cannot.

• Severe pelvic pain, fever, fainting, or sudden worsening pain
• Unexplained vaginal bleeding, especially after menopause
• New sores, discharge, burning, or possible sexually transmitted infection
• Pain with sex that is new, severe, or getting worse
• Suicidal thoughts, severe depression, panic, or trauma symptoms
• Coercion, pressure to have sex, intimate partner violence, or feeling unsafe
• A sudden libido change after starting a new medication or after a major illness

Frequently asked questions about female low sex drive treatment

Keep reading

Sexual Health

Low Sex Drive Treatment: Causes, Options, and When to Get Care

Hormone Health

Hormone Replacement Therapy With Testosterone for Women: Evidence, Risks, and Options

Hormones

Perimenopause vs Menopause Symptoms: How to Tell the Difference